Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.
Artcline has raised $5.9M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2025.
Artcline is headquartered in Rostock, Germany.
Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.
Artcline is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artcline — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/artcline. Accessed August 1, 2026.
VCBacked. (2025). Artcline — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/artcline
{{cite web |title=Artcline — Funding & Investors |url=https://www.vcbacked.co/company/artcline |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated